Stay updated on Expanded Access to Upadacitinib Clinical Trial

Sign up to get notified when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Expanded Access to Upadacitinib Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision: v3.5.2. This appears to be a maintenance/version update with no visible changes to study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-04-16T11:12:49.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0; Removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T19:20:33.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    A new revision label v3.4.3 was added and the v3.4.2 revision label was removed.
    Difference
    0.1%
    Check dated 2026-03-11T18:05:31.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 has been added, and the previous Notice about a lapse in government funding (Revision: v3.4.1) has been removed. These updates are administrative and do not affect the core study information or accessibility of the expanded access program. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-11T10:31:16.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    New government funding status notice is displayed at the top of the page. The Eligibility section was updated with new Exclusion Criteria (There are other suitable treatment options; the participant qualifies for ongoing clinical trials) and a previously listed Inclusion Criteria item was removed.
    Difference
    1%
    Check dated 2026-02-04T10:24:01.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Changes are limited to page metadata and UI labels, including a glossary toggle, updated QC-related fields (Last Update Submitted that Met QC Criteria, Last Update Posted), a No FEAR Act notice, and a revision to version 3.4.0, with older QC labeling and v3.3.4 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-01-28T06:17:48.000Z thumbnail image

Stay in the know with updates to Expanded Access to Upadacitinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.